IL-31 is produced by the malignant T-Cell population in cutaneous T-Cell lymphoma and correlates with CTCL Pruritus

Journal of Investigative Dermatology

Volumn 133, Issue 12, 2013, Pages 2783-2785

  Singer, Elisha M ^a   Shin, Daniel B ^a   Nattkemper, Leigh A ^b   Benoit, Bernice M ^a   Klein, Rachel S ^a   Didigu, Chuka A ^c   Loren, Alison W ^c   Dentchev, Tzvete ^a   Wysocka, Maria ^a   Yosipovitch, Gil ^b   Rook, Alain H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BEXAROTENE; INTERLEUKIN 31; MESSENGER RNA;

CANCER STAGING; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CUTANEOUS T CELL LYMPHOMA; CYTOKINE PRODUCTION; HUMAN; LETTER; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PRURITUS; PUVA; TREATMENT OUTCOME;

EID: 84887825524     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.227     Document Type: Letter

References (13)

1. Ahern K, Gilmore ES, Poligone B (2012) Pruritus in cutaneous T-cell lymphoma: a review. J Am Acad Dermatol 67:760-8
2. Bernengo MG, Novelli M, Quaglino P et al. (2001) The releVance of the CD4 CD26-subset in the identification of circulating Sézary cells. Br J Dermatol 144:125-35
3. Diamandidou E, Cohen PR, Kurzrock R (1996) Mycosis fungoides and Sezary syndrome. Blood 88:2385-409
4. Dillon SR, Sprecher C, Hammond A et al. (2004) Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 5:752-60
5. Jones D, Dang NH, Duvic M et al. (2001) Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood. Am J Clin Pathol 115: 885-92
6. Miyagaki T, Sugaya M, Suga H et al. (2012) Increased CCL18 expression in patients with cutaneous T-cell lymphoma: association with disease severity and prognosis. J Eur Acad Dermatol Venereol 27:e60-7
7. Ohmatsu H, Sugaya M, Suga H et al. (2012) Serum IL-31 levels are increased in patients with cutaneous T-cell lymphoma. Acta Derm Venereol 92:282-3
8. Raap U, Wichmann K, Bruder M et al. (2008) Correlation of IL-31 serum levels with severity of atopic dermatitis. J Allergy Clin Immunol 122:421-3
9. Sampogna F, Frontani M, Baliva G et al. (2009) Quality of life and psychological distress in patients with cutaneous lymphoma. Br J Dermatol 160:815-22
10. Sonkoly E, Muller A, Lauerma AI et al. (2006) IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 117:411-7
11. Szegedi K, Kremer AE, Kezic S et al. (2012) Increased frequencies of IL-31-producing T cells are found in chronic atopic dermatitis skin. Exp Dermatol 21:431-6
12. Talpur R, Bassett R, Duvic M (2008) Prevalence and treatment of Staphylococcus aureus colonization in patients with mycosis fungoides and Sézary syndrome. Br J Dermatol 159:105-12
13. Yawalkar N, Ferenczi K, Jones DA et al. (2003) Profound loss of T-cell receptor repertoire complexity in cutaneous T-cell lymphoma. Blood 102:4059-66